These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38306539)

  • 41. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
    Harding C; Chadwick T; Homer T; Lecouturier J; Mossop H; Carnell S; King W; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
    Health Technol Assess; 2022 May; 26(23):1-172. PubMed ID: 35535708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.
    Lucasti C; Vasile L; Sandesc D; Venskutonis D; McLeroth P; Lala M; Rizk ML; Brown ML; Losada MC; Pedley A; Kartsonis NA; Paschke A
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6234-43. PubMed ID: 27503659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia.
    Snydman DR
    J Hosp Med; 2012; 7 Suppl 1():S2-12. PubMed ID: 23677631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment.
    Silva-Nunes J; Cardoso T
    BMC Infect Dis; 2019 Nov; 19(1):980. PubMed ID: 31752716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chinese expert consensus on the management of lower respiratory tract infections of
    Pulmonary Infection Assembly of Chinese Thoracic Society
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The change of antibiotic susceptibility in febrile urinary tract infection in childhood and adolescence during the last decade.
    Choi U; Kim E; Lyu DH; Kim KS; Park BH; Chung H; Han CH; Bae S
    Investig Clin Urol; 2022 Jan; 63(1):99-106. PubMed ID: 34983128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections.
    Mark DG; Hung YY; Salim Z; Tarlton NJ; Torres E; Frazee BW
    Ann Emerg Med; 2021 Sep; 78(3):357-369. PubMed ID: 33781606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BACTERIAL PROFILE, ANTIMICROBIAL RESISTANCE, AND FACTORS ASSOCIATED WITH URINARY TRACT INFECTION AMONG PREGNANT WOMEN AT HOSANNA TOWN HEALTH FACILITIES, CENTRAL ETHIOPIA.
    Mussema A; Admasu D; Bawore S; Abdo R; Seid A
    Georgian Med News; 2023 Sep; (342):113-121. PubMed ID: 37991965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptostreptococcus anaerobius: Pathogenicity, identification, and antimicrobial susceptibility. Review of monobacterial infections and addition of a case of urinary tract infection directly identified from a urine sample by MALDI-TOF MS.
    Legaria MC; Nastro M; Camporro J; Heger F; Barberis C; Stecher D; Rodriguez CH; Vay CA
    Anaerobe; 2021 Dec; 72():102461. PubMed ID: 34626800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duration and cessation of antimicrobial treatment.
    File TM
    J Hosp Med; 2012; 7 Suppl 1():S22-33. PubMed ID: 23677632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections.
    Kreter B
    Clin Ther; 1992; 14(1):110-21. PubMed ID: 1576620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
    Kaye KS
    J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23737333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Re: Septic shock and adequacy of early empiric antibiotics in the emergency department.
    Schaeffer EM
    J Urol; 2015 Apr; 193(4):1263-4. PubMed ID: 25890515
    [No Abstract]   [Full Text] [Related]  

  • 56. Predictors for delayed antibiotic administration among bacteraemic patients in the Emergency Department: Differences between medical and surgical interns.
    Papadimitriou-Olivgeris M; Perdikis K; Cois M; Roth L; Mykoniati S; Nusbaumer C; Monnerat LB; Duplain H
    Eur J Clin Invest; 2020 Nov; 50(11):e13324. PubMed ID: 32564358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of antibiotic resistance in urinary tract infection management: a cost-effectiveness analysis.
    Wang R; LaSala C
    Am J Obstet Gynecol; 2021 Nov; 225(5):550.e1-550.e10. PubMed ID: 34418350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
    Rice DA; Kaniga K; Lee M; Redman R
    Int J Antimicrob Agents; 2013 Apr; 41(4):388-92. PubMed ID: 23410792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible
    Dunne MW; Puttagunta S; Aronin SI; Brossette S; Murray J; Gupta V
    Microbiol Spectr; 2022 Feb; 10(1):e0235921. PubMed ID: 35138150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Imipenem/cilastatin: in vitro activity, concentrations in plasma and prostatic adenoma and therapeutic results in patients with complicated urinary tract infections].
    Naber KG; Adam D; Bauernfeind A; Hönig E
    Infection; 1986; 14 Suppl 2():S122-9. PubMed ID: 2428754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.